Moneycontrol
HomeNewsBusinessGreat time to invest in India: PM Modi tells IBM CEO Arvind Krishna

Great time to invest in India: PM Modi tells IBM CEO Arvind Krishna

Modi said the country is moving forward with the vision of a self-sufficient India so that a globally competent and disruption resilient local supply chain can be developed, according to a statement from the Prime Minister's Office.

July 20, 2020 / 19:09 IST
Story continues below Advertisement
PM Narendra Modi (File image)

This is a great time to invest in India and the country is welcoming investments in the tech sector, Prime Minister Narendra Modi told IBM CEO Arvind Krishna on Monday. In a virtual interaction with Krishna, the prime minister noted that while the world is witnessing a slowdown, FDI inflow in India is increasing.

Modi said the country is moving forward with the vision of a self-sufficient India so that a globally competent and disruption resilient local supply chain can be developed, according to a statement from the Prime Minister's Office.

Story continues below Advertisement

Talking about the impact of the COVID-19 pandemic on business culture, the prime minister said 'work from home' is being adopted in a big way and the government is constantly working towards providing infrastructure, connectivity and regulatory environment to ensure that this technological shift is smooth.

Modi also discussed the technologies associated and challenges involved in the recent decision of IBM to make 75 per cent of its employees to work from home, the statement said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show